Arabic Arabic English English French French German German
dark

Virpax Announces MMS019 Manufacturing and Supply Agreement

Virpax ® Pharmaceuticals, Inc. today announced that it has entered into a commercial manufacturing and supply agreement with Seqens, an integrated global leader in pharmaceutical solutions with 24 manufacturing sites worldwide and seven research and development facilities throughout the U.S. and Europe. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Lilly and Lycia Ink $1.6 Billion+ Collaboration and Licensing Deal

Next Post

PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services

Related Posts
Total
0
Share